Incidence of Newly-Diagnosed Dementia After COVID-19 Infection versus Acute Upper Respiratory Infection: A Retrospective Cohort Study
Journal of Alzheimer's Disease · 30.05.2023 · 93 (3) · 1033-1040
DOI: 10.3233/jad-221271 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 30.05.2023. Verfasst von Celina Gollop und 5 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology, IQVIA, Frankfurt, Germany. Hauptthemen laut MEDLINE: Dementia, COVID-19, Alzheimer Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
There is emerging evidence that coronavirus disease 2019 (COVID-19) is giving rise to seemingly unrelated clinical conditions long after the infection has resolved.
Objective
The aim of this study is to examine whether COVID-19 is associated with an increased risk of dementia including Alzheimer’s disease.
Methods
This retrospective cohort study is based on longitudinal data from the IQVIATM Disease Analyzer database and included patients aged≥65 with an initial diagnosis of COVID-19 or acute upper respiratory infection (AURI) from 1,293 general practitioner practices between January 2020 and November 2021. AURI patients were matched 1 : 1 with COVID-19 patients using propensity scores based on sex, age, index quarter, health insurance type, the number of doctor visits, and comorbidities associated with dementia risk. Incidence rates of newly-diagnosed dementia were calculated using the person-years method. Poisson regression models were used to compute the incidence rate ratios (IRR).
Results
The present study included 8,129 matched pairs (mean age 75.1 years, 58.9% females). After 12 months of follow-up, 1.84% of the COVID-19 patients and 1.78% of the AURI patients had been diagnosed with dementia. The Poisson regression model resulted in an IRR of 1.05 (95% CI: 0.85–1.29).
Conclusion
This study did not find any association between COVID-19 infection and one-year dementia incidence after controlling for all common risk factors for dementia. Because dementia is a progressive disease, which can be difficult to diagnose, a longer follow-up period might offer a better insight into a possible association between COVID-19 infection and an increased incidence of dementia cases in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Epidemiology, IQVIA, Frankfurt, Germany.
- Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, ISCIII, Dr. Antoni Pujadas, Barcelona, Spain.
- Department of Physical Medicine and Rehabilitation, Lariboisière-Fernand Widal Hospital, AP-HP, University Paris Cité, Paris, France.
- Centre for Health, Performance, and Wellbeing, Anglia Ruskin University, Cambridge, UK.
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
Zitieren
APA
Gollop, C., Zingel, R., Jacob, L., Smith, L., Koyanagi, A., & Kostev, K. (2023). Incidence of Newly-Diagnosed Dementia After COVID-19 Infection versus Acute Upper Respiratory Infection: A Retrospective Cohort Study. Journal of Alzheimer's Disease, 93(3), 1033-1040. https://doi.org/10.3233/jad-221271
Vancouver
Gollop C, Zingel R, Jacob L, Smith L, Koyanagi A, Kostev K. Incidence of Newly-Diagnosed Dementia After COVID-19 Infection versus Acute Upper Respiratory Infection: A Retrospective Cohort Study. Journal of Alzheimer's Disease. 2023;93(3):1033-1040. doi:10.3233/jad-221271
BibTeX
@article{Gollop2023,
author = {Gollop, Celina and Zingel, Rebecca and Jacob, Louis and Smith, Lee and Koyanagi, Ai and Kostev, Karel},
title = {Incidence of Newly-Diagnosed Dementia After COVID-19 Infection versus Acute Upper Respiratory Infection: A Retrospective Cohort Study},
journal = {Journal of Alzheimer's Disease},
year = {2023},
volume = {93},
number = {3},
pages = {1033--1040},
doi = {10.3233/jad-221271}
}
EUVIMED